Author

Jacques J. Bergman 1

1 Academic Medical Centre,Amsterdam,Netherlands

ENDOSCOPIC DUODENAL MUCOSAL RESURFACING TREATMENT FOR TYPE 2 DIABETES: EARLY MULTICENTRE EXPERIENCE

Annieke C. G. van Baar, Jacques Deviere, Guido Costamagna, M. Passos Galvão Neto, Leonardo Rodríguez, Rehan Jamil Haidry, Jacques J. Bergman

ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED HIGH-RISK MUCOSAL ADENOCARCINOMA AND LOW- AND HIGH-RISK SUBMUCOSAL ADENOCARCINOMA ARISING IN BARRETT'S ESOPHAGUS, RESULTS OF 120 PATIENTS FROM THE DUTCH BARRETT EXPERT CENTER COHORT

Esther Nieuwenhuis, Sanne van Munster, Bas L.A.M. Weusten, Alaa Alkhalaf, Boudewijn Edwin Schenk, Erik Jan Schoon, Wouter L. Curvers, Arjun D. Koch, Steffi E.M. van de Ven, Eva Verheij, Aydan Kumcu, Wouter B. Nagengast, Martin Houben, Jacques J. Bergman, Roos E. Pouw

Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Bas L.A.M. Weusten, Raf Bisschops, Emmanuel Coron, Mario Dinis-Ribeiro, Jean-Marc Dumonceau, Jose Miguel Esteban, Cesare Hassan, Oliver Pech, Alessandro Repici, Jacques J. Bergman, Massimiliano di Pietro

ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES

Eva Verheij, Sanne van Munster, George Johan Arnold Offerhaus, Lodewijk Brosens, Sybren L. Meijer, Erik Jan Schoon, Bas L.A.M. Weusten, Boudewijn Edwin Schenk, Wouter L. Curvers, Arjun D. Koch, Jacques J. Bergman, Laurèlle Van Tilburg, Martin Houben, Steffi E.M. van de Ven, Thjon J. Tang, Roos E. Pouw, Wouter B. Nagengast;;

ERCP in babies: low risk of post-ERCP-pancreatitis - results from a European multicenter survey

Martin Götz, Philipp Andersen, Jacques J. Bergman, Nicola Frei, Georg Kähler, Peter Martus, Alexander Dechêne

FEASIBILITY OF A COMPUTER ALGORITHM FOR DETECTION OF  EARLY BARRETT?S NEOPLASIA USING VOLUMETRIC LASER ENDOMICROSCOPY

AnneFré Swager, Fons van der Sommen, Svitlana Zinger, Sybren L. Meijer, Erik Jan Schoon, Jacques J. Bergman, Peter de With, Wouter L. Curvers

First in-human (FIH) study on the Safety, Tolerability and Efficacy of the AquaMedical focal RF-vapor ablation (RFVA) system, for the eradication of Barrett's Esophagus (BE)

Sanne van Munster, Roos E. Pouw, Bas L.A.M. Weusten, Jacques J. Bergman

FIRST IN-HUMAN STUDY ON THE SAFETY, TOLERABILITY AND EFFICACY OF THE AQUAMEDICAL FOCAL RF-VAPOR ABLATION (RFVA) SYSTEM, FOR THE ERADICATION OF BARRETT'S ESOPHAGUS (BE): THE STEAM-BE DOSIMETRY STUDY

Sanne van Munster, Eva Verheij, Roos E. Pouw, Bas L.A.M. Weusten, Jacques J. Bergman

FIRST-IN-MAN PILOT STUDY: FEASIBILITY OF LASER MARKING IN BARRETT?S ESOPHAGUS WITH VOLUMETRIC LASER ENDOMICROSCOPY

AnneFré Swager, A J de Groof, Sybren L. Meijer, Bas L.A.M. Weusten, Wouter L. Curvers, Jacques J. Bergman

FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA

Charlotte N. Frederiks, Anouk Overwater, Lorenza Alvarez Herrero, Alaa Alkhalaf, Raf Bisschops, Jacques J. Bergman, Roos E. Pouw, Alessandro Repici, Rehan J. Haidry, Torsten Beyna, Bas L.A.M. Weusten, Horst Neuhaus

Item 31 - 40 / 137
1 2 3
4
5 6 7
...
13 14